Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges (Q37660174)

21 August 2017

1 reference

title

Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges (English)

1 reference

21 August 2017

0 references

0 references

0 references

chronic heart failure

1 reference

3

Stephan von Haehling

1 reference

21 August 2017

4

Stefan D Anker

1 reference

21 August 2017

1

Mitja Lainscak

1 reference

21 August 2017

2

Markus S Anker

1 reference

21 August 2017

publication date

1 December 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

34

1 reference

21 August 2017

issue

8

1 reference

21 August 2017

page(s)

589-593

1 reference

The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Role and importance of biochemical markers in clinical cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Atrial natriuretic peptide and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Use of biomarkers in the management of heart failure: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Cardiac troponin and outcome in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

State of the art: using natriuretic peptide levels in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Use of B-type natriuretic peptide outside of the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Brain natriuretic peptide versus atrial natriuretic peptide--physiological and pathophysiological significance in children and adults: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Effect of anemia on exercise tolerance in chronic heart failure in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Cardiac cachexia: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

The relationship between cholesterol and survival in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

The endotoxin-lipoprotein hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Structure and expression of the human cystatin C gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3316-4

Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone?!

1 reference

12 December 2020

Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge

1 reference

12 December 2020

Uric acid in chronic heart failure: a marker of chronic inflammation

1 reference

12 December 2020

Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study

1 reference

12 December 2020

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

12 December 2020

10.1007/S00059-009-3316-4

Identifiers

DOI

1 reference

21 August 2017

1 reference